Phase II
Phase II
Clinical trials of about 100-300 subjects with the condition of interest; includes pharmacokinetic, dose ranging, safety and efficacy, and is well-controlled.
Clinical trials of about 100-300 subjects with the condition of interest; includes pharmacokinetic, dose ranging, safety and efficacy, and is well-controlled.